These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2533147)

  • 1. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
    Crook D; Gardner R; Worthington M; Nolan J; Stevenson JC; Shaw RW
    Horm Res; 1989; 32 Suppl 1():157-60. PubMed ID: 2533147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.
    Dlugi AM; Rufo S; D'Amico JF; Seibel MM
    Fertil Steril; 1988 May; 49(5):913-6. PubMed ID: 3129319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women.
    Fåhraeus L; Larsson-Cohn U; Ljungberg S; Wallentin L
    Fertil Steril; 1984 Jul; 42(1):52-7. PubMed ID: 6724013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study.
    Dmowski WP; Radwanska E; Binor Z; Tummon I; Pepping P
    Fertil Steril; 1989 Mar; 51(3):395-400. PubMed ID: 2493400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis.
    Schweppe KW; Assmann G
    Horm Metab Res; 1984 Nov; 16(11):593-7. PubMed ID: 6510890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis.
    Välimäki M; Nilsson CG; Roine R; Ylikorkala O
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1097-103. PubMed ID: 2531153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goserelin versus danazol in the treatment of endometriosis.
    Giorgino FL; Cetera C; de Laurentiis G
    Clin Exp Obstet Gynecol; 1991; 18(2):127-31. PubMed ID: 1833094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
    Stevenson JC; Lees B; Gardner R; Shaw RW
    Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.
    Burry KA; Patton PE; Illingworth DR
    Am J Obstet Gynecol; 1989 Jun; 160(6):1454-9; discussion 1459-61. PubMed ID: 2525337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of danazol in the management of endometriosis.
    Young MD; Blackmore WP
    J Int Med Res; 1977; 5 Suppl 3():86-91. PubMed ID: 913886
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
    Lemay A; Brideau NA; Forest JC; Dodin S; Maheux R
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):305-10. PubMed ID: 1836425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA; Truglia JA; Caplan RJ
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine effects of danazol in the treatment of endometriosis.
    Bevan JR; Dowsett M; Jeffcoate SL
    Br J Obstet Gynaecol; 1984 Feb; 91(2):160-6. PubMed ID: 6538094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis.
    Luciano AA; Hauser KS; Chapler FK; Davis WA; Wallace RB
    Am J Obstet Gynecol; 1983 Feb; 145(4):422-6. PubMed ID: 6824034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol, high density lipoprotein and danazol.
    Allen JK; Fraser IS
    J Clin Endocrinol Metab; 1981 Jul; 53(1):149-52. PubMed ID: 7240372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoproteins during and after danazol treatment.
    Fåhraeus L; Larsson-Cohn U; Ljungberg S; Wallentin L
    Acta Obstet Gynecol Scand Suppl; 1984; 123():133-5. PubMed ID: 6594004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
    Maouris P; Dowsett M; Rose G; Edmonds DK; Rothwell C; Robertson WR
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
    Dawood MY; Spellacy WN; Dmowski WP; Gambrell RD; Greenblatt RB; Girard Y; Lemay A; Mishell DR; Nagamani M; Pepperell RJ
    Prog Clin Biol Res; 1990; 323():253-67. PubMed ID: 2106142
    [No Abstract]   [Full Text] [Related]  

  • 19. Danazol in endometriosis.
    Ratnapala SR
    Ceylon Med J; 1982 Mar; 27(1):42-5. PubMed ID: 7151242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of pelvic endometriosis with danazol].
    Garcea N; Siccardi P; Caruso A; Campo S
    Minerva Ginecol; 1980 Nov; 32(11):1049-56. PubMed ID: 7219815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.